Jean-Paul was President and Chief Executive Officer at Syntimmune, and Executive Vice President, President International and Head of Global Therapeutic Operations at Biogen. Jean-Paul Kress joined Sanofi in 2024.
Jean-Paul Kress is currently
Create your alert
to follow the career of Jean-Paul Kress.
Jean-Paul Kress has a Medical Doctor from Université René Descartes (Paris V) and a Master of Science in Molecular And Cellular Pharmacology from École normale supérieure.
They have also studied at Université René Descartes (Paris V) :
Find more alumni from Université René Descartes (Paris V)
They have also studied at École normale supérieure :
Find more alumni from École normale supérieure
Do you need to know more about Jean-Paul Kress? More results.
Report an error
Update the org chart details of Jean-Paul Kress.
Here are a few tips for establishing great contacts.
Discover the organization charts of your favorite companies.
Spot the influential executives using our search tools.
Receive notifications when executive positions change.